Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/medivir-ab--interim-report-january--march-2024-302131228.html
https://www.prnewswire.com/news-releases/medivir-to-present-data-for-the-combination-of-fostrox--lenvima-in-hcc-at-esmo-gi-302129837.html
https://www.prnewswire.com/news-releases/fda-grants-medivirs-miv-711-rare-pediatric-disease-designation-and-orphan-drug-designation-for-the-treatment-of-legg-calve-perthes-disease-302127216.html
https://www.prnewswire.com/news-releases/medivir-provides-update-from-supportive-type-c-meeting-with-the-fda-preparations-for-enhanced-phase-2b-in-hcc-with-fostrox--lenvima-continue-302124266.html
https://www.prnewswire.com/news-releases/medivirs-partner-vetbiolix-announces-positive-results-from-proof-of-concept-study-with-vbx-1000-previously-known-as-miv-701-302116699.html
https://www.prnewswire.com/news-releases/medivir-to-present-at-investing-in-oncology-forum-on-april-10-302111731.html
https://www.prnewswire.com/news-releases/medivir-2023-annual-report-published-302108380.html
https://www.prnewswire.com/news-releases/medivir-to-present-at-the-life-science-day-in-gothenburg-on-march-6-302078275.html
https://www.prnewswire.com/news-releases/medivir-announces-the-outcome-of-the-directed-share-issue-which-was-announced-on-22-january-2024-302045564.html